Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Pill versus usual care for mild to moderate hypertension
ACTRN12612001120864Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan, amlodipine and chlorthalidone in hypertension (HTN) (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: Proportion achieving target blood pressure at 6 months. Started Feb 2016; status: completed.
02
Drugs
telmisartanamlodipinechlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12612001120864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001120864.